- Home
- TNXP vs CRGO Comparison
TNXP vs CRGO Comparison
Compare TNXP & CRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- CRGO
- Stock Information
- Founded
- TNXP 2007
- CRGO 2012
- Country
- TNXP United States
- CRGO Spain
- Employees
- TNXP N/A
- CRGO N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- CRGO Blank Checks
- Sector
- TNXP Health Care
- CRGO Finance
- Exchange
- TNXP Nasdaq
- CRGO Nasdaq
- Market Cap
- TNXP 173.9M
- CRGO 165.6M
- IPO Year
- TNXP N/A
- CRGO N/A
- Fundamental
- Price
- TNXP $18.49
- CRGO $3.44
- Analyst Decision
- TNXP Buy
- CRGO
- Analyst Count
- TNXP 1
- CRGO 0
- Target Price
- TNXP $70.00
- CRGO N/A
- AVG Volume (30 Days)
- TNXP 851.8K
- CRGO 77.3K
- Earning Date
- TNXP 11-07-2025
- CRGO 11-17-2025
- Dividend Yield
- TNXP N/A
- CRGO N/A
- EPS Growth
- TNXP N/A
- CRGO N/A
- EPS
- TNXP N/A
- CRGO N/A
- Revenue
- TNXP $9,831,000.00
- CRGO $27,155,000.00
- Revenue This Year
- TNXP $14.79
- CRGO $27.63
- Revenue Next Year
- TNXP $933.49
- CRGO $24.42
- P/E Ratio
- TNXP N/A
- CRGO N/A
- Revenue Growth
- TNXP N/A
- CRGO 27.02
- 52 Week Low
- TNXP $6.76
- CRGO $1.27
- 52 Week High
- TNXP $130.00
- CRGO $4.42
- Technical
- Relative Strength Index (RSI)
- TNXP 31.62
- CRGO 53.28
- Support Level
- TNXP $18.53
- CRGO $3.19
- Resistance Level
- TNXP $20.58
- CRGO $3.58
- Average True Range (ATR)
- TNXP 1.09
- CRGO 0.14
- MACD
- TNXP 0.41
- CRGO -0.01
- Stochastic Oscillator
- TNXP 7.04
- CRGO 58.49
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About CRGO Freightos Limited Ordinary shares
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.